Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
Trial details
- Registry ID
- NCT04905979
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Trial of AD113 and Atomoxetine in OSA Patients With HypertensionNCT04905979 | Apnimed | Phase 2 | Completed | 2023-01-31Actual |
| Crossover Trial of AD036 in Obstructive Sleep ApneaNCT04445688 | Apnimed | Phase 2 | Completed | 2020-12-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |